Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients
WJ Jiang, YJ Wang, B Du, SX Wang, GH Wang, M Jin… - Stroke, 2004 - Am Heart Assoc
Objective—To assess the safety and clinical efficacy of stenting for patients with symptomatic
M1 stenosis of middle cerebral artery (MCA), and to assess the significance of classification …
M1 stenosis of middle cerebral artery (MCA), and to assess the significance of classification …
Sirtuins: novel targets for metabolic disease in drug development
W Jiang - Biochemical and biophysical research communications, 2008 - Elsevier
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating
diseases such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal …
diseases such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal …
[HTML][HTML] The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis
K Wang, RL Wang, JJ Liu, J Zhou, X Li, WW Hu… - Medicine, 2018 - journals.lww.com
Background: Human telomerase reverse transcriptase (hTERT) plays an important role in
cancer progression. Recently, several clinical studies investigated how the overexpression …
cancer progression. Recently, several clinical studies investigated how the overexpression …
Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke
W Yu, WJ Jiang - Stroke and Vascular Neurology, 2018 - svn.bmj.com
Intracranial stenosis is a common cause of ischaemic strokes, in particular, in the Asian,
African and Hispanic populations. The randomised multicentre study Stenting and …
African and Hispanic populations. The randomised multicentre study Stenting and …
Outcome of patients with≥ 70% symptomatic intracranial stenosis after Wingspan stenting
WJ Jiang, W Yu, B Du, F Gao, LY Cui - Stroke, 2011 - Am Heart Assoc
Background and Purpose—There were limited data on the long-term outcome of patients
with symptomatic intracranial atherosclerotic stenosis≥ 70% after Wingspan stenting. Using …
with symptomatic intracranial atherosclerotic stenosis≥ 70% after Wingspan stenting. Using …
Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis
M Jin, X Fu, Y Wei, B Du, XT Xu, WJ Jiang - Stroke, 2013 - Am Heart Assoc
Background and Purpose—Reliable data concerning prognosis of patients with intracranial
in-stent restenosis (ISR) is lacking. We prospectively studied long-term outcomes of patients …
in-stent restenosis (ISR) is lacking. We prospectively studied long-term outcomes of patients …
Multicenter analysis of stenting in symptomatic intracranial atherosclerosis
WJ Jiang, E Cheng-Ching, A Abou-Chebl… - …, 2012 - journals.lww.com
BACKGROUND: Stenting for symptomatic intracranial atherosclerotic disease is a
therapeutic option in patients in whom medical therapy fails. OBJECTIVE: To determine the …
therapeutic option in patients in whom medical therapy fails. OBJECTIVE: To determine the …
MRI radiomic features-based machine learning approach to classify ischemic stroke onset time
YQ Zhang, AF Liu, FY Man, YY Zhang, C Li, YE Liu… - Journal of …, 2022 - Springer
Purpose We aimed to investigate the ability of MRI radiomics features-based machine
learning (ML) models to classify the time since stroke onset (TSS), which could aid in stroke …
learning (ML) models to classify the time since stroke onset (TSS), which could aid in stroke …
DC conductivities with momentum dissipation in Horndeski theories
WJ Jiang, HS Liu, H Lü, CN Pope - Journal of High Energy Physics, 2017 - Springer
A bstract In this paper, we consider two four-dimensional Horndeski-type gravity theories
with scalar fields that give rise to solutions with momentum dissipation in the dual boundary …
with scalar fields that give rise to solutions with momentum dissipation in the dual boundary …
[HTML][HTML] A simple imaging guide for endovascular thrombectomy in acute ischemic stroke: from time window to perfusion mismatch and beyond
W Yu, WJ Jiang - Frontiers in neurology, 2019 - frontiersin.org
Recent advances in medical and endovascular therapy have revolutionized stroke care.
Intravenous thrombolysis (IVT) with tissue plasminogen activator (tPA) was shown to be …
Intravenous thrombolysis (IVT) with tissue plasminogen activator (tPA) was shown to be …